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Template for Toxicants
Gene Expression Varies by Cell Type
Gene expression profiling shows that cells generally respond to tox-
icant stress by repressing genes that guide cell growth and inducing
those that govern DNA repair and other protective functions.
However, the specific genes repressed or induced vary, depending
on the cell type and—according to research presented in this
issue—the toxicant to which
the cells are exposed [EHP
112:1607–1613]. Melissa
Troester of the University of
North Carolina at Chapel
Hill and colleagues note
that this study demonstrates
the utility of microarrays in
predictive toxicology.
The current study builds
upon previous research
showing that separate breast
cancer cell lines have dis-
tinctive responses to two
different chemotherapeutic
agents, doxorubicin (DOX)
and 5-fluorouracil (5FU).
Because DOX and 5FU
have different mechanisms
of action, the researchers
hypothesized that cells treat-
ed with one compound
would express a different
transcription profile com-
pared with cells treated with
the other. In establishing
support for this hypothesis,
the researchers were also able to demonstrate that a profile of
expressed genes could serve as a template to predict the mechanism
of action for a third cancer drug, etoposide (ETOP).
The researchers cultured four breast cell lines for their experi-
ments—two each of basal-like and luminal epithelium—and deter-
mined comparable toxic concentrations for DOX, 5FU, and
ETOP at 36 hours’ exposure. Next, cell cultures were treated at
these concentrations for 12, 24, or 36 hours in order to identify
genes that were consistently expressed over time. At the end of the
treatment periods, mRNA was extracted from the cells, pooled
according to treatment and cell line, and used to create labeled
complementary DNA samples. These samples were hybridized to
microarrays representing 22,000 genes. 
Microarray analysis identified which genes had been up- or
down-regulated and revealed unique patterns of gene expression in
response to DOX and 5FU in each cell type as well as each cell
line. In general, luminal epithelial cells responded by regulating a
large number of genes—974 in one line, 883 in the other. Basal-
like epithelial cells regulated fewer genes (76 and 193) and also
exhibited significant differences in gene expression over time. The
cells exhibited a distinctly different profile at the 12-hour time
point as compared with the 24- and 36-hour points. The differ-
ence was great enough that the DOX-treated samples clustered
with 5FU-treated samples at 12 hours but not at 24 or 36 hours.
This temporal shift blurred the lines between profiles and affected
the accuracy of predictions.
Further investigation pinpointed 100 genes that could be used
to differentiate between DOX- and 5FU-treated samples. This list
of genes provided the basis for the final evaluation—testing
whether the mechanism of action for ETOP could be accurately
classified based upon the genes expressed following exposure.
Because ETOP acts by a mechanism similar to that of DOX, it was
expected that the gene set expressed by ETOP-treated cells would
more closely resemble that of DOX-treated cells as compared to
5FU-treated cells. 
Indeed, the mechanism of action for ETOP was predicted with
100% accuracy. When the researchers included cell type in the pre-
dictive model, the accuracy
dropped to 75%, due in
part to the temporal vari-
ability in gene expression in
the basal-like cell lines.
With regard to the iden-
tity of regulated genes, pub-
lished reports corroborate
this toxicant-specific expres-
sion. For example, DOX
has previously been shown
to impair cellular respira-
tion; the current research
reveals that DOX alters
mitochondrial gene expres-
sion, which provides a plau-
sible explanation for the
documented impairment.
The findings also show sev-
eral unanticipated changes
in gene expression. For
example, 5FU treatment
induced the genes ID1 and
ID3, an effect that has not
been previously noted.
Knowledge of Id proteins is
incomplete, and the resear-
chers suggest that their pathways warrant attention as potential tar-
gets for therapeutic treatments. 
Many toxicogenomics studies are providing expression data for
toxicants that have known mechanisms of action, with the eventual
goal of inferring mechanisms of action for novel compounds.
Based on the success of their own mechanistic analysis, Troester
and colleagues contend that this is feasible. –Julia R. Barrett
How E2 Induces Uterine
Effects
Transcription Coordinates Cascade 
The rodent uterotrophic assay, a standard method for assessing a
compound’s estrogenicity, offers a model for phenotypic anchor-
ing, or linking changes in gene expression to specific pathologic
changes. Typically, when an immature rodent uterus is exposed to
the endogenous estrogen 17β-estradiol (E2), it undergoes cell pro-
liferation and differentiation that can be measured through weigh-
ing and histological analysis. The uterine changes triggered by
estrogens are directed by numerous genes, but little has been
known about the molecular events involved and how they relate to
observable physical change. A wealth of detail is now provided
through research by Jonathan Moggs of Syngenta’s Central
Toxicology Laboratory in the United Kingdom and colleagues
[EHP 112:1589–1606]. According to the team’s findings, E2
induces a highly coordinated transcriptional program that orches-
trates a cascade of cellular events related to uterine growth. 
Profiles in chemistry. New research examining chemotherapeutic agents
applied to breast cancer cells shows how known gene expression profiles may
be used to predict the mechanism of action of other drugs.Science Selections
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The scientists’ findings are based on a standard rodent
uterotrophic assay. Female mice were given a single E2 or control
injection at approximately 3 weeks of age and then euthanized at
specified time intervals (1, 2, 4, 8, 24, 48, or 72 hours). After the
animals’ uteri were weighed, samples were taken for histological
analysis, and remaining tissue was subjected to RNA extraction
for microarray analysis. 
The researchers confirmed the physical events of this typical
assay. Uterine weights began to change rapidly after the E2 injec-
tions. A significant increase was seen by 4 hours, with maximum
weight gain reached at 24–72 hours. Cellular changes were also
rapid. By 4 hours after injection, the stromal endometrium had
thickened due to water uptake; cell growth and proliferation were
apparent between 8 and 24 hours. 
Total RNA was isolated from the pooled uteri for each treat-
ment group, and labeled complementary RNAs were constructed
and hybridized to microarrays to yield 42 data sets. Analysis of
gene expression led to the identification of 3,538 E2-responsive
genes. Further analysis allowed the grouping of these genes into
coregulated clusters and the identification of the predominant
gene functions associated with each cluster. Finally, by compar-
ing gene expression and changes in uterine weight and histology
with regard to time, the scientists were able to anchor changes in
gene expression to changes in uterine characteristics.
These new microarray data reveal that the interaction of an
exogenous estrogen with estrogen receptors initiates a highly
coordinated molecular cascade that drives uterine growth and cell
differentiation. The molecular program begins with the induction
of genes that regulate transcription and signal transduction. It
continues with the regulation of genes involved in protein
biosynthesis, cell proliferation, and epithelial cell differentiation.
Other gene functions are interwoven into the program, including
the direction of fluid uptake and coordination of cell division. 
With regard to time, changes in gene expression and uterine
characteristics fell into four distinct phases. In the first phase,
covering the first 4 hours after injection, E2 rapidly induced tran-
scriptional regulators and signaling components for a multitude
of pathways, including those responsible for regulating fluid
influx. The second phase, 4–8 hours after injection, was charac-
terized by induction of genes needed for mRNA and protein syn-
thesis, but no changes in physical uterine characteristics. During
the third phase, occurring 8–24 hours after injection, uterine
weight doubled, and cells entered the replication cycle, while
genes controlling chromosome regulation and cell cycle were
under active regulation. Finally, in the fourth phase, 24–72 hours
following E2 exposure, the genes being induced were those
involved in uterine cell differentiation and defense responses.
The researchers write that their findings provide a basis for
understanding the mechanisms by which other estrogenic com-
pounds, including environmental chemicals, induce their effects.
Also, the large number of E2-responsive genes that they identified
provides an array of potential marker genes that could be useful
in short-term estrogenicity assays. Finally, the scientists note that
their work provides a paradigm for understanding the mecha-
nisms of action for estrogen as well as other nuclear receptors.
–Julia R. Barrett